Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer - 27/05/14
, Renhua Guo a, ⁎, 3 Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
Gastric cancer is the second leading cause of cancer-related deaths worldwide, and is characterized by invasion and metastasis. Increasing attention is being focused on discovering molecular markers for diagnosis and prognosis. Our objective was to evaluate PI3K, Akt and survivin protein expression in gastric cancer, and their correlations with clinicohistological features and prognosis in patients with gastric cancer.
Methods |
Tissue samples were obtained from 70 patients with gastric cancer patients and 20 patients with normal gastric mucosa. The protein levels of PI3K, Akt and survivin were evaluated by immunohistochemistry. Statistical analyses were performed to establish the correlations between their expressions and patients’ clinicopathologic characteristics.
Results |
The positive expression rates of PI3K, Akt and survivin were significantly higher in the gastric cancer tissues compared to normal gastric mucosa (P<0.05). Expression levels of PI3K, Akt and survivin proteins were significantly correlated with TNM stage, differentiation grade, lymph node metastasis and metastases to other organs (P<0.05). Cooperative relationships were identified between PI3K and Akt, and PI3K and survivin (P<0.01), suggesting the involvement of the PI3K/Akt/survivin signaling pathway in the tumorigenesis of gastric cancer.
Conclusions |
Protein expression of PI3K, Akt and survivin were significantly associated with the development, progression and metastasis of gastric cancer and may have value as diagnostic and prognostic markers in gastric cancer.
Le texte complet de cet article est disponible en PDF.Keywords : Gastric cancer, PI3K/Akt/survivin, Immunohistochemistry
Plan
Vol 68 - N° 4
P. 471-475 - mai 2014 Retour au numéro
Article précédent
- PRP19 upregulation inhibits cell proliferation in lung adenocarcinomas by p21-mediated induction of cell cycle arrest
- Arko-Boham Benjamin, Xin Zhou, Okai Isaac, Haoqi Zhao, Yang Song, Xinming Chi, Bing Sun, Lihong Hao, Liyuan Zhang, Lu Liu, Hongwei Guan, Shujuan Shao
- Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro
- Engin Ulukaya, Mehmet Sarimahmut, Buse Cevatemre, Ferda Ari, Azmi Yerlikaya, Konstantinos Dimas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?